Drugs / Dibenzyl trisulphide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04113096 | Oct 2018 → Sep 2020 | breast cancer, colorectal cancer, female reproductive organ cancer, prostate cancer | The University of The West Indies | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dibenzyl trisulphide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04113096 ↗ |
| Known as | GUINEAHEN WEED | “Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer” NCT04113096 ↗ |